Cargando…

ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hypothalamic Obesity

OBJECTIVE: To assess the safety and efficacy of Tesomet (tesofensine plus metoprolol) in adults with hypothalamic obesity, a rare disease with no approved therapy. RESEARCH DESIGN AND METHODS: Twenty-one adults with hypothalamic obesity (16 females, 5 males) were randomized to Tesomet (0.5 mg tesofe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klose, Marianne, Huynh, Kim, Krogsgaard, Kim, Drejer, Jørgen, Pharm, Dr, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Researcher, Senior, Aharaz, Abdellatif, Edsberg, Berit, Tfelt, Jacob, Astrup, Arne, Feldt-Rasmussen, Ulla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625380/ http://dx.doi.org/10.1210/jendso/bvac150.1059

Ejemplares similares

Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity
por: Huynh, Kim, et al.
Publicado: (2022)

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity
por: Huynh, Kim D, et al.
Publicado: (2021)

Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
por: Sugimoto, T., et al.
Publicado: (2014)

Open Access Week, 24 to 30 October
Publicado: (2016)

Clinical response of vedolizumab at week 6 predicted endoscopic remission at week 24 in ulcerative colitis
por: Saito, Daisuke, et al.
Publicado: (2021)

Continuous growth reference from 24(th )week of gestation to 24 months by gender
por: Niklasson, Aimon, et al.
Publicado: (2008)

Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial
por: Thomsen, Mads N., et al.
Publicado: (2022)

Variability in and predictors of glycaemic responses after 24 weeks of treatment with exenatide twice daily and exenatide once weekly
por: Shaw, Jonathan E., et al.
Publicado: (2017)

Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial
por: Rugo, Hope S., et al.
Publicado: (2021)

Minutes of the QCD Meeting on 24 January 1995 (Plenary Week)
por: Settles, R
Publicado: (1995)

Healthy and Safe Swimming Week — May 18–24, 2015
Publicado: (2015)

Contact Lens Health Week — August 20–24, 2018
Publicado: (2018)

A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
por: Eghbali, Aziz, et al.
Publicado: (2017)

Contact Lens Health Week — August 24–28, 2015
Publicado: (2015)

Opportunities for Prevention of Gestational Diabetes Before 24 Weeks of Gestation
por: Cheng, Decui, et al.
Publicado: (2021)

Prediction of Prolonged Pregnancy in Nulliparous Women by Transvaginal Ultrasonographic Measurement of Cervical Length at 20-24 Weeks and 37 Weeks
por: Suh, Young Hoon, et al.
Publicado: (2007)

Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis
por: Sugimoto, T., et al.
Publicado: (2013)

Minutes of the QCD Plenary Week meeting held on 24 9 91
por: Settles, R
Publicado: (1991)

Get Smart About Antibiotics Week — November 18–24, 2013
Publicado: (2013)

24 Improved Dialysis Symptom Index with Tablo Thrice Weekly Dialysis
Publicado: (2021)

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
por: Berenbaum, Francis, et al.
Publicado: (2020)

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B
por: Piratvisuth, Teerha, et al.
Publicado: (2013)

A Matter of Health? A 24-Week Daily and Weekly Diary Study on Workplace Bullying Perpetrators’ Psychological and Physical Health
por: Özer, Gülüm, et al.
Publicado: (2022)

A 24‐week study to evaluate the efficacy and safety of once‐weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD‐8)
por: Dungan, K. M., et al.
Publicado: (2016)

Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort
por: Hill, Cian J., et al.
Publicado: (2017)

A 24-Weeks Toxicity Study of Eryngium foetidum Linn. Leaves in Mice
por: Janwitthayanuchit, Kanittha, et al.
Publicado: (2016)

Vital Statistics, &c., for Four Weeks Ended 24th April, 1926
por: Macgregor, A. S. M.
Publicado: (1926)

Vital Statistics, &c., for Four Weeks Ended 24th September, 1927
por: Macgregor, A. S. M.
Publicado: (1927)

Vital Statistics, &c., for Four Weeks Ended 24th November, 1934
por: Macgregor, A. S. M.
Publicado: (1934)

Vital Statistics, &c., for Four Weeks Ended 24th September, 1932
por: Macgregor, A. S. M.
Publicado: (1932)

Vital Statistics, &c., for Four Weeks Ended 24th November, 1928
por: Macgregor, A. S. M.
Publicado: (1928)

Vital Statistics, &c., for Four Weeks Ended 24th February, 1934
por: Macgregor, A. S. M.
Publicado: (1934)

Lung Function Decline after 24 Weeks of Moxa Smoke Exposure in Rats
por: He, Rui, et al.
Publicado: (2019)

Exercise and obstructive sleep apnoea: a 24-week follow-up study
por: Karlsen, Trine, et al.
Publicado: (2022)

Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment
por: Blevins, Thomas, et al.
Publicado: (2016)

A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52 : A protocol for mixed treatment comparisons meta-analysis
por: Zhang, Nie, et al.
Publicado: (2019)

The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study
por: Bae, Sang-Cheol, et al.
Publicado: (2022)

Establishing Postnatal Growth Monitoring Curves of Preterm Infants in China: Allowing for Continuous Use from 24 Weeks of Preterm Birth to 50 Weeks
por: Zong, Xin’nan, et al.
Publicado: (2022)

Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study
por: Ho, Ling Yin, et al.
Publicado: (2007)

Minutes of the Z0 Physics preparation meeting ALEPH WEEK, 24 2 89
por: Harton, J
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_990jdi93bicc3v7kk4qcgaoark